Our Clinical Research Training Fellows for 2023/24 have now been appointed. Seven healthcare professionals from a range of different disciplines and backgrounds will be undertaking PhD training and delivering innovative research to help improve the health of people living in East London.
With our funding, researchers at Queen Mary University of London have found that children living in areas with high levels of deprivation in North East London, are three times more likely to have severe tooth decay that requires dental extraction in hospital.
The MBE recognises Professor Chloe Orkin’s services to the NHS, including pioneering work to find new therapies for HIV for underrepresented groups, funded by Barts Charity.
Research part-funded by Barts Charity shows that blocking certain enzymes could significantly halt acute myeloid leukaemia (AML), a particularly aggressive type of blood cancer.
Barts Charity funded research from Queen Mary University of London, suggests that girls between the ages of four and 11 who are considered overweight or obese were 1.7 times more likely to visit GP with a musculoskeletal symptom or diagnosis.
With our funding researchers at Queen Mary will investigate how marks on DNA in our blood - and the information they contain - can be used to detect a wider range of diseases than before, early and accurately.
A study led by Queen Mary University of London has, for the first time, identified cells that drive the spread of pancreatic cancer. A weakness in these cells could be targeted using existing drugs.
Research funded by Barts Charity and led by Queen Mary, suggests that people may experience long-term health impacts following acute respiratory infections including cold, influenza and pneumonia that are not due to Covid-19, and that may be going unrecognised.
A new study highlights the importance of a more inclusive approach to drug testing, to ensure that it is effective across different ethnicities.
Research funded by Barts Charity, conducted at Queen Mary University of London and St Bartholomew's Hospital, has identified a gene variant that causes a common type of high blood pressure (known as hypertension) and proposes a cure which could help many people currently going undiagnosed.
